Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report

Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report

Abstract Background The approach to acromegalic patients with persistent acromegaly after surgery and inadequate response to first-generation somatostatin receptor ligands (SRLs) should be strictly tailored. Current options include new pituitary surgery and/or radiosurgery, or alternative medical tr...

Full description

Bibliographic Details
Main Authors: A. Ciresi, S. Radellini, V. Guarnotta, C. Giordano
Format: Article
Language:English
Published: BMC 2018-01-01
Series:BMC Endocrine Disorders
Subjects:
Pasireotide
Pegvisomant
Acromegaly
Cotreatment
Resistant
Online Access:http://link.springer.com/article/10.1186/s12902-018-0231-9

Internet

http://link.springer.com/article/10.1186/s12902-018-0231-9

Similar Items